Active surveillance may be an alternative to surgery for localized renal tumors
the ONA take:
According to a recent study published in The Journal of Urology, in patients likely to have surgery for kidney cancer, close monitoring of small renal tumors is associated with low rates of cancer growth or mortality.
The standard of care for patients with tumors confined to the kidneys is surgical excision, but in ill or elderly patients, the risk of surgical complications may outweigh the benefits.
For the study, researchers identified 68 patients with clinically localized renal tumors. Of those 45 patients received active surveillance while 23 progressed to intervention. Results showed that localized renal tumors 4cm or greater in diameter showed growth rates similar to those of small tumors managed with active surveillance.
In addition, there was a low rate of progression to metastatic disease at short-term follow-up that was comparable in both groups.
The findings suggest that close monitoring of clinically localized renal tumors may provide an alternative to surgery in order to avoid certain complications that may arise in special populations.
In patients likely to have surgery, close monitoring of small renal tumors is associated with low rates of cancer growth or mortality.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|